4th Quarter - Report

ZOETIS INC. for ZOETIS INC.

Period 4th Quarter 2014 Filed Jan 20, 2015 Signed by Kathy Mitchell

Official filing
Firm
ZOETIS INC.
Client
ZOETIS INC.
Income
—
Expenses
$300,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Agriculture AGR

Farm Bill-Legislative provision on Office of International Trade

LobbyistCovered position, as disclosed
KATHY MITCHELL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

S. 959, Pharmaceutical Compounding Quality and Accountability Act-Animal health drug compounding; H.R. 1150, Preservation of Antibiotics for Medical Treatment Act; H.R. 820, Delivering Antimicrobial Transparency in Animals Act; S. 1256, Preventing Antibiotic Resistance Act; S. 895, Antimicrobial Data Collection Act; H.R. 2285, Strategies to Address Antimicrobial Resistance Act; S. 1171, H.R. 1528, Veterinary Medicine Mobility Act

LobbyistCovered position, as disclosed
KATHY MITCHELL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1150 (113th), S. 959 (113th), S. 1256 (113th), S. 895 (113th), S. 1171 (113th), H.R. 820 (113th), H.R. 2285 (113th), H.R. 1528 (113th)

Animals ANI

HR 4023, and S 2756 Fairness to Petowners Act

LobbyistCovered position, as disclosed
KATHY MITCHELL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4023 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.